Rounds / Craif

C

Craif raises ¥5.3B (Series D)

AI analysis of urinary microRNA for cancer risk; US launch.

Company

Craif

Reported

18 Aug 2026 · that week's brief

Stage

Series D · 「シリーズD」 · D+

Amount

¥5.3B¹ · as announced: 「約53億円」

Breakdown

Equity not disclosed separately · Debt ¥500M

Status

In scopeNot yet registry-confirmed

Notes

Primary + secondary ≈48億 (not separated), loans 5億

Investors

Not listed in our summary; see source

Sector

HealthcareDeep tech

Source

Primary release (PR TIMES) · BRIDGE coverage

¹ ≈ ~$33.18M at the ECB reference rate on 2026-08-18 (¥1 = $0.00626). Yen is the figure of record. Methodology